At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 80 enrolled
Drug / intervention
Psyllium powder +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence
In Brief
A Phase 3 clinical trial evaluating Psyllium powder and Loperamide for Fecal Incontinence. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate and compare treatment with fiber and loperamide for fecal incontinence.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFecal Incontinence
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedAug 2008
Primary CompletionOct 2013
Study CompletionDec 2013
TodayJul 2026
First PostedAug 4, 2008
Enrollment StartJul 1, 2008
Primary CompletionOct 1, 2013
Study CompletionDec 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 17.9 years ago
Interventions
Psyllium powderdrug
2 teaspoons with 8 ounces of liquid daily for 28 days (weekly adjusted dose)
Loperamidedrug
1 capsule daily for 28 days (weekly adjusted dose)